MAT is endorsed by SAMHSA, NIDA, and the World Health Organization as a first-line, evidence-based treatment for opioid use disorder. The medications work by reducing withdrawal, blocking the rewarding effects of substances, or normalizing brain chemistry that was changed by long-term use.
Despite robust evidence, MAT remains underutilized in the United States — partly because of stigma rooted in older “abstinence-only” philosophies that frame any medication as a form of substitution rather than treatment.
In practice
If a habit you’re trying to change involves substance dependence, MAT is the evidence-based starting point and a clinician is the right next step. Daybreak isn’t a substitute for that medical care; we’re aimed at the everyday-habit layer above it.
Source
SAMHSA, “Medications for Substance Use Disorders.” samhsa.gov.